{
    "entities": [
        {
            "entity": "EszopicloneProductsUse",
            "description": "Any past year use of Eszopiclone Products, including Lunesta or other sedatives containing eszopiclone."
        },
        {
            "entity": "ZaleplonProductsUse",
            "description": "Any past year use of Zaleplon Products, including Sonata or generic zaleplon."
        },
        {
            "entity": "BenzodiazepineSedativesUse",
            "description": "Any past year use of Benzodiazepine Sedatives, including flurazepam, temazepam, or triazolam."
        },
        {
            "entity": "TriazolamProductsUse",
            "description": "Any past year use of Triazolam Products, including Halcion or generic triazolam."
        },
        {
            "entity": "TemazepamProductsUse",
            "description": "Any past year use of Temazepam Products, including Restoril or generic temazepam."
        },
        {
            "entity": "PositiveResponse",
            "description": "Indicates whether the respondent used a specific drug product in the past year."
        },
        {
            "entity": "NegativeResponse",
            "description": "Indicates whether the respondent did not use a specific drug product in the past year."
        },
        {
            "entity": "FrequencyPercentage",
            "description": "The frequency and percentage of respondents who reported use of specific drug products."
        }
    ],
    "relationships": [
        {
            "relationship": "hasPositiveResponse",
            "source_entity": "Respondent",
            "target_entity": "PositiveResponse",
            "description": "Indicates that a respondent used a specific drug product in the past year."
        },
        {
            "relationship": "hasNegativeResponse",
            "source_entity": "Respondent",
            "target_entity": "NegativeResponse",
            "description": "Indicates that a respondent did not use a specific drug product in the past year."
        },
        {
            "relationship": "reportsFrequencyPercentage",
            "source_entity": "Survey",
            "target_entity": "FrequencyPercentage",
            "description": "Provides the frequency and percentage of respondents who reported use of specific drug products."
        }
    ],
    "triplets": [
        {
            "subject": "RC-ESZOPICLONE PRODUCTS - ANY PAST YEAR USE",
            "predicate": "freq",
            "object": "33"
        },
        {
            "subject": "RC-ESZOPICLONE PRODUCTS - ANY PAST YEAR USE",
            "predicate": "pct",
            "object": "0.06"
        },
        {
            "subject": "RC-ZALEPLON PRODUCTS - ANY PAST YEAR USE",
            "predicate": "freq",
            "object": "33"
        },
        {
            "subject": "RC-ZALEPLON PRODUCTS - ANY PAST YEAR USE",
            "predicate": "pct",
            "object": "0.06"
        },
        {
            "subject": "RC-BENZODIAZEPINE SEDATIVES - ANY PAST YEAR USE",
            "predicate": "freq",
            "object": "14"
        },
        {
            "subject": "RC-BENZODIAZEPINE SEDATIVES - ANY PAST YEAR USE",
            "predicate": "pct",
            "object": "0.02"
        },
        {
            "subject": "RC-TRIAZOLAM PRODUCTS - ANY PAST YEAR USE",
            "predicate": "freq",
            "object": "14"
        },
        {
            "subject": "RC-TRIAZOLAM PRODUCTS - ANY PAST YEAR USE",
            "predicate": "pct",
            "object": "0.02"
        },
        {
            "subject": "RC-TEMAZEPAM PRODUCTS - ANY PAST YEAR USE",
            "predicate": "freq",
            "object": "14"
        },
        {
            "subject": "RC-TEMAZEPAM PRODUCTS - ANY PAST YEAR USE",
            "predicate": "pct",
            "object": "0.02"
        }
    ]
}